In-depth biotech analysis articles - Labiotech.eu

Sarcoma research: is a breakthrough in sight?

Roohi Mariam Peter — Mon, 24 Jul 2023 14:24:40 +0000

Among the rarest forms of cancers, sarcomas develop in the bones and connective tissues that support structures in the body like blood vessels, nerves and joints. This year, around 13,400 new cases of soft tissue sarcomas are estimated to be diagnosed in the U.S. alone, according to the American Cancer Society. As July marks Sarcoma […]

The post Sarcoma research: is a breakthrough in sight? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

How AI is shaping clinical research and trials

Willow Shah-Neville — Fri, 21 Jul 2023 10:31:56 +0000

Artificial intelligence (AI) is everywhere at the minute, seemingly being used in some capacity in almost every professional industry, including clinical research and trials. In fact, it is fair to say that AI has taken the biotech industry by storm, and the hype surrounding it has led to numerous AI startup companies coming onto the […]

The post How AI is shaping clinical research and trials appeared first on Labiotech.eu.

Genetic engineering giants: is China poised to lead the way?

Willow Shah-Neville — Wed, 19 Jul 2023 15:57:04 +0000

For many people, when they hear China and genetic engineering in the same sentence, it is often synonymous with scandal, and gene-edited babies may spring to mind. And, although it is true that nearly five years ago, researcher He Jiankui infamously claimed he had created the first ever gene-edited babies, before going to prison for […]

The post Genetic engineering giants: is China poised to lead the way? appeared first on Labiotech.eu.

Ten years to ten days: French startup revolutionizes early diagnosis of endometriosis with a saliva test

Roohi Mariam Peter — Tue, 18 Jul 2023 11:13:13 +0000

A condition that affects around 190 million women and girls worldwide, according to the World Health Organization, endometriosis is a chronic, difficult-to-treat disease that causes debilitating pelvic pain. Often misdiagnosed as irritable bowel syndrome (IBS) and sometimes dismissed as menstrual cramps, the diagnosis of endometriosis can take around 10 years, raising the severity of the […]

The post Ten years to ten days: French startup revolutionizes early diagnosis of endometriosis with a saliva test appeared first on Labiotech.eu.

Gold rush over: what happens to biotech now that venture capital is out of reach?

Willow Shah-Neville — Thu, 13 Jul 2023 15:49:31 +0000

If you were to look back just a little over two years ago to the start of 2021, then putting money into a biotech company seemed like a pretty safe bet. After all, the COVID-19 pandemic had shined a positive spotlight on the biopharmaceutical industry, and initial public offerings (IPOs) were booming. But the last […]

The post Gold rush over: what happens to biotech now that venture capital is out of reach? appeared first on Labiotech.eu.

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

Roohi Mariam Peter — Wed, 12 Jul 2023 15:17:31 +0000

With a combined market value of over $7 billion, the life science sectors in Sweden and Denmark are thriving, with over a thousand healthcare companies being set up over the past few years. Much of this is owing to the cross-border cluster that spans regions of eastern Denmark and southern Sweden, the Medicon Valley. Racking […]

The post Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden appeared first on Labiotech.eu.

AIS Biotech: startup employs carbohydrates to fight the flu

Roohi Mariam Peter — Tue, 11 Jul 2023 11:19:28 +0000

Keen on discovering novel ways to tackle viral infections, AIS Biotech, a French company based in the Alps, aims to combat influenza, more commonly known as the flu, by leveraging the medicinal promise behind glycobiotechnology. A field that has been gaining momentum over the past decade, glycobiotechnology is the study of complex carbohydrates which has […]

The post AIS Biotech: startup employs carbohydrates to fight the flu appeared first on Labiotech.eu.

“Ready-to-use” enzymatically produced cell-free synthetic DNA in mRNA manufacturing

External Contributor — Mon, 10 Jul 2023 14:36:43 +0000

By Ashish Dhir, PhD and Amy Walker, PhD, 4basebio The pace, efficacy and scalability with which the success of mRNA vaccines against COVID-19 was demonstrated opened endless possibilities for mRNA medicine in broad areas of infectious diseases, cancers, protein-encoding replacement therapies. The advantages of RNA medicine are obvious, with the ease and speed of design […]

The post “Ready-to-use” enzymatically produced cell-free synthetic DNA in mRNA manufacturing appeared first on Labiotech.eu.

Making an impact through targeting mRNA

Jim Cornall — Mon, 10 Jul 2023 12:00:00 +0000

Biotech company Molecure develops small molecule therapies that can regulate RNA and underexplored protein targets for the treatment of incurable diseases, including cancer and fibrotic and inflammatory diseases. The company, which was named as one of our 10 biotech companies leading the charge in Poland, told Labiotech that its RNA platform finds small molecules that […]

The post Making an impact through targeting mRNA appeared first on Labiotech.eu.

Unleashing the potential: Optimizing mRNA for the discovery of transformative medicines

External Contributor — Mon, 10 Jul 2023 09:34:05 +0000

By Dr. Alexander Zehnder, CEO, CureVac The success of mRNA vaccines in COVID-19 propelled the role of this new modality to the forefront of medicine. Not only are new prophylactic mRNA vaccines for various respiratory diseases advancing through clinical development, but mRNA medicines are now being developed in many wide-ranging applications, including cancer and rare […]

The post Unleashing the potential: Optimizing mRNA for the discovery of transformative medicines appeared first on Labiotech.eu.

The future of food: what’s behind the cell-cultured meat industry regulations?

Roohi Mariam Peter — Fri, 07 Jul 2023 11:47:38 +0000

The first-ever lab-grown burger was created at Maastricht University in the Netherlands, and eaten at a news conference in London in 2013. While everyone who tried a bite had something different to say about the taste and texture of the meat, it was agreed that this could be the start of something big. The technology […]

The post The future of food: what’s behind the cell-cultured meat industry regulations? appeared first on Labiotech.eu.

The biggest private biotech investments in June 2023

Willow Shah-Neville — Thu, 06 Jul 2023 10:43:21 +0000

The companies Upstream Bio, Alkeus Pharmaceuticals and Worg Pharmaceuticals bagged the biggest biotech investments in June 2023, with oncology and ophthalmology players in particular attracting the most funding rounds. Overall, more funding rounds took place in June 2023 than in May, and the U.S. healthcare sector once again attracted particularly big rounds. We’ve gathered the […]

The post The biggest private biotech investments in June 2023 appeared first on Labiotech.eu.

Hepatitis B: are we edging closer to a cure?

Willow Shah-Neville — Mon, 03 Jul 2023 15:27:29 +0000

A viral infection that affects the liver and can cause both acute and chronic disease, hepatitis B affects around 296 million people worldwide, and, according to the latest statistics from the World Health Organization (WHO), it resulted in an estimated 820,000 deaths in 2019. The virus is most commonly transmitted to children during childbirth, but […]

The post Hepatitis B: are we edging closer to a cure? appeared first on Labiotech.eu.

The promise of immunotherapy for autoimmune diseases

Roohi Mariam Peter — Tue, 27 Jun 2023 14:01:44 +0000

Our immune system serves as the body’s chief line of defense against harmful invaders. But what happens when this mighty defense mechanism turns on its own host, launching an assault on healthy cells and tissues? For the millions of people battling autoimmune diseases, this can severely affect their lives. However, advances in immunotherapy have revolutionized […]

The post The promise of immunotherapy for autoimmune diseases appeared first on Labiotech.eu.

Brace yourself for a wave of biotech layoffs

Roohi Mariam Peter — Thu, 22 Jun 2023 09:00:00 +0000

In the ever-evolving field of biotechnology spearheaded by discoveries that fuel therapeutic success, of late, the industry is taking measures to optimize the workforce amid economic uncertainty. Or to put it plainly, the biotech industry is now faced with a string of layoffs. And following the lead of big pharmas like AbbVie and Bristol Myers […]

The post Brace yourself for a wave of biotech layoffs appeared first on Labiotech.eu.

Gene therapy: a promising solution for sickle cell disease

Willow Shah-Neville — Mon, 19 Jun 2023 10:00:00 +0000

Sickle cell disease is debilitating, and many people who suffer with it find that their lives are defined by pain. This means a curative treatment would be completely life–altering, and, as we observe World Sickle Cell Day on June 19, we explore how gene therapy could be the most promising solution for curing sickle cell […]

The post Gene therapy: a promising solution for sickle cell disease appeared first on Labiotech.eu.

Can ChatGPT be used to advance drug discovery?

Willow Shah-Neville — Fri, 16 Jun 2023 10:00:00 +0000

Chat GPT – which is a large language model (LLM) and belongs to a family of artificial intelligence (AI) known as generative AI – has been a revelation for many people around the world, and, since its launch, has been used by professionals in many industries to assist with work-related tasks, such as editing and […]

The post Can ChatGPT be used to advance drug discovery? appeared first on Labiotech.eu.

How are biotechs addressing rare chromosome disorders?

Roohi Mariam Peter — Wed, 14 Jun 2023 10:29:50 +0000

Human beings typically have 23 pairs of chromosomes. But sometimes, in rare cases, an error during cell division can result in cells having extra or missing chromosomes, indicative of chromosomal disorders. Often, prenatal tests are carried out to detect chromosomal abnormalities. Amniocentesis is a diagnostic procedure where the amniotic fluid that protects a fetus during […]

The post How are biotechs addressing rare chromosome disorders? appeared first on Labiotech.eu.

Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines

External Contributor — Tue, 13 Jun 2023 12:29:31 +0000

By Dr. Andrea Pfeifer, CEO of AC Immune SA The clinical success we’ve recently seen with two monoclonal antibodies that target the protein amyloid beta (Abeta) has provided hope for patients, a significant boost to the sector but also a strong validation of the “amyloid hypothesis”: removing Abeta plaques is a valid therapeutic strategy for […]

The post Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines appeared first on Labiotech.eu.

Enhancing canine wellness: The promise of immunotherapy for dogs

Willow Shah-Neville — Fri, 09 Jun 2023 11:14:45 +0000

Given that dogs are widely regarded as ‘man’s best friend’, it makes sense that we are constantly striving to find ways to improve canine health. One method that has been – and is still being – explored is the use of immunotherapy, which uses a dog’s own immune system to fight health issues, such as […]

The post Enhancing canine wellness: The promise of immunotherapy for dogs appeared first on Labiotech.eu.